A biased Gm haplotype and Gm paraprotein allotype in multiple myeloma suggests a role for the Gm system in myeloma development

International Journal of Immunogenetics

Volumn 34, Issue 2, 2007, Pages 119-125

  Ilic V ^a   Milosevic Jovcic N ^a   Markovic D ^a   Petrovic S ^a   Stefanovic G ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; PARAPROTEIN;

ALLOTYPE; ARTICLE; CHROMOSOME 14Q; CHROMOSOME DISORDER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; POPULATION; PRIORITY JOURNAL; PROTEIN ISOLATION; SERUM GROUP GM SYSTEM; YUGOSLAVIA;

CHROMOSOMES, HUMAN, PAIR 14; HAPLOTYPES; HETEROZYGOTE; HUMANS; IMMUNOGLOBULIN GM ALLOTYPES; MULTIPLE MYELOMA; PARAPROTEINS;

EID: 33947263215     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2007.00673.x     Document Type: Article

References (41)

1. Bakkus, M.H.C., Van Riet, I., De Greef, C., Van Camp, B. & Thielemans, K. (1995) The clonogenic precursor cell in multiple myeloma. Leukemia & Lymphoma, 18, 221.
2. Bäsecke, J., Griesinger, F., Trümper, L. & Brittinger, G. (2002) Leukemia- and lymphoma-associated aberrations in healthy individuals. Annals of Hematology, 81, 64.
3. Benjamin, M., Reddy, S. & Brawley, O.W. (2003) Myeloma and race: a review of the literature. Cancer Metastasis Review, 22, 87.
4. Bergsagel, P.L. & Kuehl, W.M. (2001) Chromosome translocation in multiple myeloma. Oncogene, 20, 5611.
5. Blake, P.J. & Greally, J.F. (1975) Gm and Inv markers in whole myeloma sera in an Irish population. Journal of Immunogenetics, 2, 147.
6. Bland, J.M. & Altman, D.G. (2000) The odds ratio. British Medical Journal, 320, 1468.
7. Dougier, H.L., Reynaud, S., Pinaud, E., Carrion, C. & Cogne, M. (2006) Interallelic class switch recombination can reverse allelic exclusion and allow trans-complementation of an IgH locus switching defect. European Journal of Immunology, 36, 2181.
8. Dugoujon, J.M. & Cambon-Thomsen, A. (1995) Immunoglobulin allotypes (Gm and Km) and their interactions with HLA antigens in autoimmune diseases: a review. Autoimmunity, 22, 245.
9. Dugoujon, J.M., Hazout, S., Loirat, F., Mourrieras, B., Crouau-Roy, B. & Sanchez-Mazas, A. (2004) GM haplotype diversity of 82 populations over the world suggests a centrifugal model of human migrations. American Journal of Physical Anthropology, 125, 175.
10. Fenton, J.A., Pratt, G., Rawstrom, A.C. & Morgan, G.J. (2002) Isotype class switching and the pathogenesis of multiple myeloma. Hematological Oncology, 20, 75.
11. Fonseca, R., Bailey, R.J., Ahmann, G.J., Rajkumar, S.V., Hoyer, J.D., Lust, J.A., Kyle, R.A., Gertz, M.A., Greipp, Ph.R. & Dewald, G.W. (2002) Genomic abnormalities in monoclonal gammopathy of undetermined significance. Blood, 100, 1417.
12. Gabrea, A., Bergsagel, P.L., Chesi, M., Shou, Y. & Kuehl, M.W. (1999) Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell. Molecular Cell, 3, 119.
13. Guikema, J.E.J., Hovenga, S., Vellenga, E. & Bos, N.A. (2004) Heterogeneity in the multiple myeloma tumor clone. Leukemia & Lymphoma, 45, 857.
14. Hassan, M.S., Islam, K.B., Hammarström, L. & Smith, C.I.E. (1992) Regulation of Cγ3 expression. Role of switch in the allotype-associated variation of human serum IgG3 levels. Journal of Immunology, 148, 255.
15. Ho, P.J., Brown, R.D., Pelka, G.J., Basten, A., Gibson, J. & Joshua, D.E. (2001) Illegitimate switch recombinations are present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survival. Blood, 97, 490.
16. Irsch, J., Hendricks, R., Tesch, H., Schuurman, R. & Radbruch, A. (1993) Evidence for human IgG1 class switch program. European Journal of Immunology, 23, 481.
17. Kosmas, C., Viniou, N., Stamatopulos, K., Courtenay-Luck, N.S., Papadaki, T., Kollia, P., Paterakis, G., Anagnostou, D. & Yataganas, X. (1996) Analysis of the κ light chain variable region in multiple myeloma. British Journal of Haematology, 94, 306.
18. Krawinkel, U. & Radbruch, A. (1987) Immunoglobulin heavy chain class switching. In: Molecular Genetics of Immunoglobulin (ed. by F. Calabi & M.S. Neuberger), p. 135. Elsevier Science, Amsterdam.
19. Langman, R.E. & Cohn, M. (1995) The proportion of B-cell subset expressing κ and 1 light chains changes following antigenic selection. Immunology Today, 16, 141.
20. Leech, S.H., Brown, R. & Schanfield, M.S. (1985) Genetic studies in multiple myeloma. II. Immunoglobulin allotype associations. Cancer, 55, 1473.
21. Lefranc, M.P. & Lefranc, G. (1990) Molecular genetics of immunoglobulin allotype expression. In: The Human IgG Subclasses (ed. by F. Shakib), p. 43. Pergamon Press, Oxford.
22. Lewis, D.R., Pottern, L.M., Brown, L.M., Silverman, D.T., Haves, R.B., Schoenberg, J.B. et al. (1994) Multiple myeloma among blacks and whites in the United States: the role of chronic antigenic stimulation. Cancer Causes and Control, 5, 529.
23. Litwin, S.D. & Fudenberg, H.H. (1972) Quantitative abnormalities of allotypic genes in families with primary immune deficiencies. Proceedings of the National Academy of Sciences of the USA, 69, 1739.
24. Milošević-Jovčić, N., Ilić, V., Petrović, S. & Marković, D. (2006) Signaling status of IgG B cell receptor (BCR) in multiple myeloma. 16th European Congress of Immunology/1st Joint Meeting of European National Societies of Immunology, 6 September 2006, Paris, Oral presentation, Abstract No. WD18-125, p 26.
25. Nakao, Y., Matsumoto, H., Tsuji, K., Miyazaki, T., Masaoka, T., Nakyama, S., Kinoshita, K., Shingami, T., Matsui, T. & Fujita, T. (1984) IgG heavy chain allotype (Gm), a genetic marker for human chromosome 14q32, and haematopoietic malignancies. Clinical and Experimental Immunology, 56, 628.
26. Nikolić, V., Milošević, N., Šuš aković, N. & Miletić, V. (1979) Distribution of four IgG Gm antigens in different experimental IgG samples. Vox Sanguinis, 37, 257.
27. Nikolić, V., Milošević-Jovèić, N., Mijatović, N. & Šušaković, N. (1987) Frequency of Gm factors of immunoglobulin G among several populations in Serbia. Genetika, 19, 183.
28. Nishida, K., Tamura, A. & Nakazawa, N. (1997) The Ig heavy chain gene is frequently involved in chromosomal translocation in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood, 90, 526.
29. Ota, T., Higashi, S., Suzuki, H. & Eto, S. (1991) Enzyme linked immunosorbent assay (ELISA) for human IgG (Gm) allotype determination. Molecular Immunology, 28, 51.
30. Pan, Q., Rabbani, H., Mills, F.C., Severinson, E. & Hammarström, L. (1997) Allotype-associated variation in the human gamma3 switch region as a basis for differences in IgG3 production. Journal of Immunology, 158, 5849.
31. Pilarski, L., Masells-Smith, A., Szczepek, A., Mant, M.J. & Belch, A.R. (1996) Circulating clonotypic B cells in the biology of multiple myeloma. Speculations on the origin of myeloma. Leukemia & Lymphoma, 22, 357.
32. Pratt, G. (2002) Molecular aspects of multiple myeloma. Journal of Clinical Pathology: Molecular Pathology, 55, 273.
33. Radl, J., Wels, J. & Hoogeveen, C.M. (1988) Immunoblotting with (sub) class-specific antibodies reveals a high frequency of monoclonal gammopathies in persons thought to be immunodeficient. Clinical Chemistry, 34, 1839.
34. H gene sequences reveal a complementary imprint of antigen selection in tumor cells. Blood, 89, 219.
35. Salier, J.P., Sarvas, H., Reisner, H.M., Wang, A.C. & Fudenberg, H.H. (1979) Quantitative studies of Gm allotypes - III. Some effects of IgG aggregation in radioimmunoassays using human IgM and rabbit IgG anti-Gm antibodies. Molecular Immunology, 16, 217.
36. Scott, M.G., Briles, D.E. & Nahm, M.H. (1990) Selective IgG subclass expression: biologic, clinical and functional aspects. In: The Human IgG Subclasses (ed. by F. Shakib), p. 161. Pergamon Press, Oxford.
37. Steinberg, A.G. & Cook, C.E. (1981) The Distribution of the Human Immunoglobulin Allotypes. Oxford University Press, Oxford.
38. Stevenson, G.T. & Kan, K.S. (1997) Chemically engineered antibodies. In: Immunochemistry 1. A Practical Approach (ed. by A.P. Johnstone & M.W. Turner), p. 1. IRL Press at Oxford University Press, Oxford.
39. Vanasse, G.J., Concannon, P. & Willerford, D.M. (1999) Regulated genomic instability and neoplasia in the lymphoid lineage. Blood, 94, 3997.
40. Whittingham, S. & Propert, D.N. (1986) Gm and Km allotypes, immune response and disease susceptibility. Monographs in Allergy, 19, 52.
41. Whittingham, S., Mackay, I.R. & Mathews, J.D. (1984) HLA-Gm interactions: clinical implications. Clinical Immunological Alergy, 4, 623.